ghk-cu clinical studies dosage human 7% ACCELERANT GHK-Cu Copper Peptide: Dosage, Before
Description
,
Unlike many other peptide programs, ours is overseen by a board-certified physician, ensuring that every treatment plan is medically sound and tailored to individual needs
Based on these studies it seems that the nitrogen retaining properties of GH predominantly involve stimulation of protein synthesis without affecting (lowering) proteolysis
Fully customized formulas, custom molds, special packaging, or advanced testing may need longer development time
